133 related articles for article (PubMed ID: 34902628)
1. Intestinal HIF-2α Regulates GLP-1 Secretion via Lipid Sensing in L-Cells.
Mooli RGR; Mukhi D; Pasupulati AK; Evers SS; Sipula IJ; Jurczak M; Seeley RJ; Shah YM; Ramakrishnan SK
Cell Mol Gastroenterol Hepatol; 2022; 13(4):1057-1072. PubMed ID: 34902628
[TBL] [Abstract][Full Text] [Related]
2. Activation of intestinal hypoxia-inducible factor 2α during obesity contributes to hepatic steatosis.
Xie C; Yagai T; Luo Y; Liang X; Chen T; Wang Q; Sun D; Zhao J; Ramakrishnan SK; Sun L; Jiang C; Xue X; Tian Y; Krausz KW; Patterson AD; Shah YM; Wu Y; Jiang C; Gonzalez FJ
Nat Med; 2017 Nov; 23(11):1298-1308. PubMed ID: 29035368
[TBL] [Abstract][Full Text] [Related]
3. The HIF-2α/PPARα pathway is essential for liraglutide-alleviated, lipid-induced hepatic steatosis.
Wang H; Wang L; Li Y; Luo S; Ye J; Lu Z; Li X; Lu H
Biomed Pharmacother; 2021 Aug; 140():111778. PubMed ID: 34062416
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of HIF-2α in pancreatic β cells does not alter glucose homeostasis.
Brunt JJ; Shi SY; Schroer SA; Sivasubramaniyam T; Cai EP; Woo M
Islets; 2014; 6(5-6):e1006075. PubMed ID: 25833250
[TBL] [Abstract][Full Text] [Related]
5. Maternal intestinal HIF-2α is necessary for sensing iron demands of lactation in mice.
Ramakrishnan SK; Anderson ER; Martin A; Centofanti B; Shah YM
Proc Natl Acad Sci U S A; 2015 Jul; 112(28):E3738-47. PubMed ID: 26124130
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-inducible factor-2α mediates the adaptive increase of intestinal ferroportin during iron deficiency in mice.
Taylor M; Qu A; Anderson ER; Matsubara T; Martin A; Gonzalez FJ; Shah YM
Gastroenterology; 2011 Jun; 140(7):2044-55. PubMed ID: 21419768
[TBL] [Abstract][Full Text] [Related]
7. Intestine-specific Disruption of Hypoxia-inducible Factor (HIF)-2α Improves Anemia in Sickle Cell Disease.
Das N; Xie L; Ramakrishnan SK; Campbell A; Rivella S; Shah YM
J Biol Chem; 2015 Sep; 290(39):23523-7. PubMed ID: 26296885
[TBL] [Abstract][Full Text] [Related]
8. Ezetimibe stimulates intestinal glucagon-like peptide 1 secretion via the MEK/ERK pathway rather than dipeptidyl peptidase 4 inhibition.
Chang E; Kim L; Choi JM; Park SE; Rhee EJ; Lee WY; Oh KW; Park SW; Park DI; Park CY
Metabolism; 2015 May; 64(5):633-41. PubMed ID: 25704082
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of prolyl hydroxylases increases hepatic insulin and decreases glucagon sensitivity by an HIF-2α-dependent mechanism.
Riopel M; Moon JS; Bandyopadhyay GK; You S; Lam K; Liu X; Kisseleva T; Brenner D; Lee YS
Mol Metab; 2020 Nov; 41():101039. PubMed ID: 32534258
[TBL] [Abstract][Full Text] [Related]
10. Yhhu4488, a novel GPR40 agonist, promotes GLP-1 secretion and exerts anti-diabetic effect in rodent models.
Guo DY; Li DW; Ning MM; Dang XY; Zhang LN; Zeng LM; Hu YH; Leng Y
Biochem Biophys Res Commun; 2015 Oct; 466(4):740-7. PubMed ID: 26417688
[TBL] [Abstract][Full Text] [Related]
11. Hepatocyte-specific HIF-1α ablation improves obesity-induced glucose intolerance by reducing first-pass GLP-1 degradation.
Lee YS; Riopel M; Cabrales P; Bandyopadhyay GK
Sci Adv; 2019 Jul; 5(7):eaaw4176. PubMed ID: 31281892
[TBL] [Abstract][Full Text] [Related]
12. Temporal induction of intestinal epithelial hypoxia-inducible factor-2α is sufficient to drive colitis.
Solanki S; Devenport SN; Ramakrishnan SK; Shah YM
Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G98-G107. PubMed ID: 31241981
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia-inducible factor-2α is essential in activating the COX2/mPGES-1/PGE2 signaling axis in colon cancer.
Xue X; Shah YM
Carcinogenesis; 2013 Jan; 34(1):163-9. PubMed ID: 23042097
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-inducible factor 2α (HIF-2α) promotes colon cancer growth by potentiating Yes-associated protein 1 (YAP1) activity.
Ma X; Zhang H; Xue X; Shah YM
J Biol Chem; 2017 Oct; 292(41):17046-17056. PubMed ID: 28848049
[TBL] [Abstract][Full Text] [Related]
15. HIF-2α-induced upregulation of CD36 promotes the development of ccRCC.
Liao M; Li Y; Xiao A; Lu Q; Zeng H; Qin H; Zheng E; Luo X; Chen L; Ruan XZ; Yang P; Chen Y
Exp Cell Res; 2022 Dec; 421(2):113389. PubMed ID: 36252650
[TBL] [Abstract][Full Text] [Related]
16. Lenticular cytoprotection. Part 1: the role of hypoxia inducible factors-1α and -2α and vascular endothelial growth factor in lens epithelial cell survival in hypoxia.
Neelam S; Brooks MM; Cammarata PR
Mol Vis; 2013; 19():1-15. PubMed ID: 23335846
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-inducible factor-2α mediates senescence-associated intrinsic mechanisms of age-related bone loss.
Lee SY; Park KH; Lee G; Kim SJ; Song WH; Kwon SH; Koh JT; Huh YH; Ryu JH
Exp Mol Med; 2021 Apr; 53(4):591-604. PubMed ID: 33811248
[TBL] [Abstract][Full Text] [Related]
18. Oxygen therapy alleviates hepatic steatosis by inhibiting hypoxia-inducible factor-2α.
Yu L; Wang H; Han X; Liu H; Zhu D; Feng W; Wu J; Bi Y
J Endocrinol; 2020 Jul; 246(1):57-67. PubMed ID: 32369776
[TBL] [Abstract][Full Text] [Related]
19. Differential regulation of the transcriptional activities of hypoxia-inducible factor 1 alpha (HIF-1alpha) and HIF-2alpha in stem cells.
Hu CJ; Iyer S; Sataur A; Covello KL; Chodosh LA; Simon MC
Mol Cell Biol; 2006 May; 26(9):3514-26. PubMed ID: 16611993
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-inducible transcription factor 2α promotes steatohepatitis through augmenting lipid accumulation, inflammation, and fibrosis.
Qu A; Taylor M; Xue X; Matsubara T; Metzger D; Chambon P; Gonzalez FJ; Shah YM
Hepatology; 2011 Aug; 54(2):472-83. PubMed ID: 21538443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
